Mesothelin (MSLN)-directed CAR-NK92 cells demonstrated effective elimination of MSLN-expressing cell lines (OVCAR-3 and SKOV3), and of subcutaneous and intraperitoneal ovarian cancer in mice models. The gene discussed is MSLN; the disease is ovarian carcinoma.